Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

We had the cure for death from malnutrition, and we took it away.” We speak to surgeon and health policy expert Atul Gawande ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

The Preeclampsia Foundation, a US-based not-for-profit focused on improving outcomes from hypertensive disorders of pregnancy, has been announced as one of 80+ organizations that were awarded funding ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

The trial evaluated treatment responses in patients who were virologically suppressed, switching from a multi-tablet regimen ...

When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...

Africa must break the cycle of dependency that has long defined its health landscape. The continent cannot continue to rely on donors to finance cures for problems its own economic model perpetuates.

Background “Prevention is better than cure,” they say. But what happens when prevention is no longer enough, when we have crossed that line and are confronted with the painful reality of a disease ...

ZimEye Controversial preacher and businessman Prophet Walter Magaya, founder of the Prophetic Healing and Deliverance (PHD) ...